Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice

Amin Daei Sorkhabi1, Erfan Komijani2, Aila Sarkesh1

  • 1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Summary

Immune checkpoint inhibitors show promise for treating multiple sclerosis (MS) by restoring immune balance. Strategies focus on modulating inhibitory and stimulatory checkpoints to combat MS-related neurodegeneration.

Related Concept Videos